JAMDA
Volume 8, Issue 8 , Pages 502-510, October 2007

Optimizing Insulin Use in Type 2 Diabetes: Role of Basal and Prandial Insulin in Long-Term Care Facilities

  • Linda B. Haas, PhC, RN, CDE

      Affiliations

    • Corresponding Author InformationAddress correspondence to Linda Haas, PhC, RN, CDE, VA Puget Sound Health Care System, University of Washington School of Nursing, 1660 S. Columbian Way (S-118), Seattle, WA 98108–1597.

VA Puget Sound Health Care System, Seattle, WA.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 I have served on a diabetes advisory board for sanofi-aventis U.S. from 2004 to the present and hold stock in Amylin Pharmaceuticals. I have no other financial interest in any product discussed in the manuscript.

 Editorial support has been provided by sanofi-aventis U.S.

PII: S1525-8610(07)00353-2

doi:10.1016/j.jamda.2007.08.002

JAMDA
Volume 8, Issue 8 , Pages 502-510, October 2007